Scarica l'app Stockscreener
172.58
2.02%
-3.55
Dopo l'orario di chiusura:
172.62
0.04
+0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EFX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$176.13
Aprire:
$172.4
Volume 24 ore:
841.19K
Relative Volume:
0.48
Capitalizzazione di mercato:
$20.28B
Reddito:
$6.28B
Utile/perdita netta:
$703.80M
Rapporto P/E:
30.39
EPS:
5.6784
Flusso di cassa netto:
$1.14B
1 W Prestazione:
+0.02%
1M Prestazione:
+8.73%
6M Prestazione:
-14.31%
1 anno Prestazione:
-28.16%
Intervallo 1D:
$171.51
$175.72
Intervallo di 1 settimana:
$171.51
$190.15
Portata 52W:
$150.75
$271.84
Equifax Inc Stock (EFX) Company Profile
Nome
Equifax Inc
Settore
Industria
Telefono
(404) 885-8000
Indirizzo
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
172.58 | 20.83B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
194.85 | 27.08B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
69.72 | 8.59B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
159.31 | 4.88B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
151.77 | 1.89B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-16 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Ripresa | BofA Securities | Buy |
| 2025-10-13 | Iniziato | Oppenheimer | Outperform |
| 2025-10-01 | Iniziato | Seaport Research Partners | Neutral |
| 2025-07-10 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-10 | Ripresa | BofA Securities | Buy |
| 2025-04-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Downgrade | Argus | Buy → Hold |
| 2024-12-16 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Iniziato | UBS | Buy |
| 2024-09-19 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Iniziato | Wells Fargo | Overweight |
| 2024-07-09 | Iniziato | Wolfe Research | Outperform |
| 2024-02-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-01-04 | Reiterato | Needham | Buy |
| 2023-12-19 | Iniziato | Oppenheimer | Outperform |
| 2023-12-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-12-15 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Iniziato | Citigroup | Buy |
| 2023-07-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-11-15 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Iniziato | Deutsche Bank | Hold |
| 2022-03-11 | Ripresa | BofA Securities | Neutral |
| 2022-01-31 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Aggiornamento | Truist | Hold → Buy |
| 2022-01-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Aggiornamento | Argus | Hold → Buy |
| 2021-10-15 | Ripresa | Evercore ISI | Outperform |
| 2021-07-23 | Reiterato | Goldman | Neutral |
| 2021-07-08 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Aggiornamento | Stifel | Hold → Buy |
| 2020-12-08 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Iniziato | Needham | Buy |
| 2020-07-10 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Downgrade | SunTrust | Buy → Hold |
| 2020-05-15 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Downgrade | Argus | Buy → Hold |
| 2020-03-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Aggiornamento | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Aggiornamento | Argus | Hold → Buy |
| 2019-11-22 | Iniziato | Jefferies | Buy |
| 2019-03-15 | Iniziato | Exane BNP Paribas | Underperform |
| 2019-02-05 | Downgrade | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Ripresa | Credit Suisse | Outperform |
| 2018-10-26 | Reiterato | Barclays | Equal Weight |
| 2018-10-23 | Ripresa | BofA/Merrill | Underperform |
| 2018-04-10 | Iniziato | BofA/Merrill | Underperform |
| 2017-12-14 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Equifax Inc Borsa (EFX) Ultime notizie
Equifax Inc (EFX) Valuation: PE, PB & Fair Value Analysis - TradingKey
EFX|Equifax Inc|Price:177.330|Chg%:+4.790 - TradingKey
Daily Brief Industrials: Deutsche Lufthansa , BYD Company, Raytheon Technologies , Lockheed Martin, Union Pacific, Honeywell International, Equifax Inc, LHN, Croma Security Solutions Group, Comfort Systems Usa and more - Smartkarma
Daily Brief Health Care: Apnimed, Chugai Pharmaceutical, Equifax Inc, Royalty Pharma , Startline, Surgery Partners, Teva Pharmaceutical Sp Adr, Thermo Fisher Scientific Inc and more - Smartkarma
Daily Brief South Korea: SK Hynix, SK Inc, Naver Corp, Chaevi, Equifax Inc and more - Smartkarma
Equifax Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
(EFX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Unlocking Equifax (EFX) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Equifax: Valuation Has Already Priced In FY2026 Guide (NYSE:EFX) - Seeking Alpha
Equifax Inc (EFX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equifax Q3 Outlook Pressured by Contract Signing Delays, Oppenheimer Says - Moomoo
Equifax Inc (EFX) Shares Surge 3.5% -- What GF Score of 75 Tells Investors - GuruFocus
Equifax Inc. stock outperforms competitors on strong trading day - MarketWatch
Equifax Launches $1 Billion Senior Notes Offering Featuring Attractive Interest Rates - Kalkine Media
Is Equifax (EFX) Undervalued On Earnings Guidance Buybacks And New Notes? - Sahm
A Quick Look at Today's Ratings for Equifax(EFX.US), With a Forecast Between $179 to $235 - Moomoo
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
EQUIFAX INC. : WELLS FARGO CUTS TARGET PRICE TO $212 FROM $220 - webull.com
Equifax (EFX) Q2 2026 earnings summary - Quartr
Analysts Are Bullish on These Industrial Goods Stocks: Equifax (EFX), Rocket Lab USA (RKLB) - The Globe and Mail
Equifax, Inc. (EFX) Stock Forecasts - Yahoo Finance
EQUIFAX INC : JP MORGAN CUTS TARGET PRICE TO $210 FROM $230 - Bitget
Equifax Inc Files Pricing Term Sheet For Two-Part Senior Notes Offering Of $1 BillionSEC Filing - TradingView
Equifax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
Is Equifax (EFX) A Bargain As New Debt Clouds Its Valuation? - Yahoo Finance
Is Equifax’s Q2 Results and Círculo de Crédito Deal Altering The Investment Case For Equifax (EFX)? - Sahm
Equifax Says Inflation Is Hitting Lower-Income Consumers - Sahm
EFX Maintained by Morgan Stanley -- Price Target Lowered to $225 - GuruFocus
EFX Maintains by Baird -- Price Target Lowered to $232 - GuruFocus
Deutsche Bank Adjusts Equifax Price Target to $208 From $217, Maintains Buy Rating - Moomoo
EFX Maintains by RBC Capital -- Price Target Lowered to $194.00 - GuruFocus
Morgan Stanley Adjusts Price Target on Equifax to $225 From $243, Maintains Overweight Rating - Moomoo
Barclays Adjusts Price Target on Equifax to $200 From $215, Maintains Equalweight Rating - Moomoo
JPMorgan Adjusts Equifax Price Target to $210 From $230 - Moomoo
Wells Fargo Adjusts Price Target on Equifax to $212 From $220, Maintains Overweight Rating - Moomoo
These Analysts Slash Their Forecasts On Equifax After Q2 Results - Benzinga
BNP Paribas Adjusts Price Target on Equifax to $190 From $185, Maintains Neutral Rating - Moomoo
Needham Adjusts Price Target on Equifax to $245 From $265, Maintains Buy Rating - marketscreener.com
Needham lowers Equifax stock price target to $245 on guidance - Investing.com
Needham lowers Equifax stock price target to $245 on guidance By Investing.com - Investing.com Canada
EQUIFAX INC : NEEDHAM CUTS TARGET PRICE TO $245 FROM $265 - Bitget
Baird Adjusts Price Target on Equifax to $232 From $245, Maintains Outperform Rating - Moomoo
RBC Cuts Price Target on Equifax to $194 From $222, Keeps Outperform Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Equifax to $182 From $173, Maintains Neutral Rating - marketscreener.com
Equifax Inc at Goldman Sachs U.S. Financial Services Conference Transcript - GuruFocus
Q3 2025 Equifax Inc Earnings Call Transcript - GuruFocus
Equifax (EFX) Reports Q2 Earnings, Misses EPS Expectations - GuruFocus
Q4 2025 Equifax Inc Earnings Call Transcript - GuruFocus
RBC Capital cuts Equifax stock price target on GenAI concerns - Investing.com
RBC Capital cuts Equifax stock price target on GenAI concerns By Investing.com - Investing.com Canada
Equifax Inc Azioni (EFX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Equifax Inc Azioni (EFX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Begor Mark W | CEO |
Jul 24 '26 |
Sale |
172.16 |
37,791 |
6,506,255 |
271,890 |
2.75%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):